2017
DOI: 10.1111/tog.12390
|View full text |Cite
|
Sign up to set email alerts
|

Update on hysteroscopic sterilisation

Abstract: Women need to be informed of the long-term risks to be able to make an informed choice. Detailed discussion and awareness is needed to allow selecting the right method of contraception, covering both the positive and negative aspect of the method. Medico-legal implications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 38 publications
0
2
0
Order By: Relevance
“…With the FDA approval to use nickel titanium (nitol) occlusion material in the tubal ostium in hysteroscopy, the application of hysteroscopic sterilization is becoming more popular. 6 Globally, it is estimated that about 15% of women who had tubal sterilization regret their choice due to various reasons, for example, change of marital status, loss of the child, or change of attitude. 3 Accordingly, any possible way to restore the fertility status in females who underwent tubal sterilization is an important issue.…”
Section: Discussionmentioning
confidence: 99%
“…With the FDA approval to use nickel titanium (nitol) occlusion material in the tubal ostium in hysteroscopy, the application of hysteroscopic sterilization is becoming more popular. 6 Globally, it is estimated that about 15% of women who had tubal sterilization regret their choice due to various reasons, for example, change of marital status, loss of the child, or change of attitude. 3 Accordingly, any possible way to restore the fertility status in females who underwent tubal sterilization is an important issue.…”
Section: Discussionmentioning
confidence: 99%
“…Clinicians will have to wait for future hysteroscopic alternatives to emerge to broaden the choice for women once more. This will be difficult in the light of the lawsuits attracted by Essure and the withdrawal of Adiana in 2012 due to its high failure rate and the manufacturer’s inability to keep up with legal costs over patent infringement litigation 2…”
mentioning
confidence: 99%